Latest News about Stories That Matter
Recent news which mentions Stories That Matter
Southwest Airlines Beats Q3 Street Expectations, Secures Agreement With Elliott Management-Driven Board Overhaul
October 24, 2024
From Benzinga
From Benzinga
Social Media Reacts As Juul Users Get Compensation Through Venmo After $300M Class-Action Settlements: 'Vaping Actually Paid Off'
October 24, 2024
From Benzinga
Nvidia Chases Growth in India: AI Partnerships With Reliance, Infosys, Wipro, Expanding into Robotics And Key Industries
October 24, 2024
From Benzinga
JPMorgan Vs. Global X: Which High-Yield Dividend ETF Is The Better Pick As Fed Cuts Interest Rates?
October 24, 2024
From Benzinga
After Gold's 'Moment In The Sun,' It's Now Silver's Turn: These ETFs Linked To The Shiny Metal Are Rising In Thursday's Pre Market
October 24, 2024
From Benzinga
From Benzinga
Monopoly Maker Hasbro Inventory Falls 39% In Q3, CFO Vows To Finish 2024 With Improved Profitability
October 24, 2024
From Benzinga
19-Year-Old Walmart Employee Found Dead In Walk-In Oven In Canada
October 24, 2024
From Benzinga
From Benzinga
Uber, Lyft Shares Are Sliding In Premarket Today: Is Elon Musk's Robotaxi Plan The Reason?
October 24, 2024
From Benzinga
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
October 24, 2024
From Benzinga
Asia Mixed, Europe Gains, Crude Oil Jumps 2% On Geopolitical Concerns, Gold Advances - Global Markets Today While US Slept
October 24, 2024
From Benzinga
Tesla Soars In Thursday Pre-Market: Here's What's Driving The Surge
October 24, 2024
From Benzinga
Boeing Stock Falls Deeper In Red Premarket As Troubles Mount
October 24, 2024
From Benzinga
Billionaire Bob Duggan Snags $33M Miami Penthouse Amid Summit Therapeutics 689% Stock Rally
October 24, 2024
From Benzinga
Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
October 23, 2024
From Benzinga
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
From Benzinga
Lucid CEO Throws Cold Water On Tesla's Robotaxi Vision, Says Self-Driving Cars Won't Happen 'Till The 2030s'
October 23, 2024
From Benzinga
Bitcoin, Ethereum, Dogecoin Correct: 'A Bounce From This Region Would Be Ideal,' Says Trader
October 23, 2024
From Benzinga
30-Year Treasury Yield Tops 4.50%, Raising Red Flags For Markets: 'Bond Vigilantes Are Voting Early,' Says Veteran Investor
October 23, 2024
From Benzinga
Tesla Q3 Earnings Highlights: EPS Beat, Revenue Miss, Shares Climb On 2025 Timeline For Lower-Cost EVs
October 23, 2024
From Benzinga
Apple, Goldman Sachs Fined $89 Million Over Apple Card Missteps, Government Watchdog Orders Victim Compensation
October 23, 2024
From Benzinga
Blinken Pushes For Cease-Fire As Israel Strikes Historic Lebanese City, Gallant Escalates Threats Against Iran
October 23, 2024
From Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
October 23, 2024
From Benzinga
Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal
October 23, 2024
From Benzinga
From Benzinga
Philip Morris' Q3 Driven By Smoke-Free Products Amid Rising Market Share In Key Regions: Analyst Forecasts Growth Across IQOS And ZYN Brands
October 23, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.